Company intelligence / Profile preview

Domain Russia Investments

Moscow, Russia

Ownership: Private
Development stage: Other

Overview

NovaMedica is a Russia-based pharmaceutical company focused on in-licensing, local manufacture, and commercialization of innovative drugs and devices for the Russian and CIS markets. It brings products that have completed clinical development to market.

Therapeutic areas: CardiovascularOphthalmologyWomen's HealthGastroenterologyInfectious DiseasesOtherOncology
Modalities: Small moleculeBiologicMedical deviceHydrogel
Industry: Biotech

Partnerships

Domain AssociatesRUSNANORusnanoMedInvestReVision OpticsVarious US/EU biotech companies

Beyond the preview

Go deeper on Domain Russia Investments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Domain Russia Investments.

Explore the full profile